-+ 0.00%
-+ 0.00%
-+ 0.00%

Optomed Q2 EBITDA loss narrows 50.4% to EUR 457,000; revenue falls 8.6% to EUR 3.52 million vs Q2 FY25

PUBT·08/14/2026 06:06:49
Listen to the news
Optomed Q2 EBITDA loss narrows 50.4% to EUR 457,000; revenue falls 8.6% to EUR 3.52 million vs Q2 FY25
  • Optomed posted Q2 revenue down 8.6% to EUR 3.52 million year over year; net loss narrowed to EUR 935,000.
  • EBITDA loss narrowed 50.4% to EUR 457,000, while gross margin rose 6.4 percentage points to 71.3%.
  • Devices revenue fell 18.4% to EUR 1.15 million; Software revenue dipped 2.9% to EUR 2.37 million.
  • Operating cash outflow improved to EUR 259,000 from EUR 1.65 million; cash totaled EUR 6.69 million at period-end.
  • Guidance reiterated for full-year 2026 revenue growth versus 2025; a USD 2.1 million U.S. device order is expected to lift H2.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optomed plc published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.